Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 23;4(4):e446–e456. doi: 10.1055/s-0040-1721735

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ )

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1 — Decision tree for continued anticoagulation in patients with VTE. ² ⁴ ⁵ ⁶ ²⁶ ⁵⁴ ^a Major persistent conditions include active cancer and antiphospholipid antibody syndrome. ^b Minor persistent defined as inflammatory bowel disease, lower extremity paralysis or paresis, congestive heart failure, BMI >30 kg/m ² , creatinine clearance <50 mL/min, family history of VTE, hereditary thrombophilia and acquired thrombophilia. Minor transient defined as immobilization, travel >8 hours and leg injury with impaired mobility. BMI, body mass index; DVT, deep vein thrombosis; HERDOO2, Hyperpigmentation, Edema, or Redness in either leg; D-dimer level ≥ 250 μg/L; Obesity with body mass index ≥ 30; or Older age, ≥ 65 years; VTE, venous thromboembolism.